11-64237511-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000309422.7(VEGFB):c.502C>T(p.Pro168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000645 in 1,611,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000309422.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VEGFB | NM_003377.5 | c.502C>T | p.Pro168Ser | missense_variant | 6/7 | ENST00000309422.7 | NP_003368.1 | |
VEGFB | NM_001243733.2 | c.411-10C>T | intron_variant | NP_001230662.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VEGFB | ENST00000309422.7 | c.502C>T | p.Pro168Ser | missense_variant | 6/7 | 1 | NM_003377.5 | ENSP00000311127.2 | ||
VEGFB | ENST00000426086.3 | c.411-10C>T | intron_variant | 1 | ENSP00000401550.2 | |||||
VEGFB | ENST00000543462.1 | n.97-10C>T | intron_variant | 2 | ||||||
VEGFB | ENST00000541681.1 | c.-27C>T | upstream_gene_variant | 3 | ENSP00000442526.1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152174Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000933 AC: 23AN: 246526Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134318
GnomAD4 exome AF: 0.0000384 AC: 56AN: 1459686Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 726212
GnomAD4 genome AF: 0.000315 AC: 48AN: 152292Hom.: 0 Cov.: 31 AF XY: 0.000363 AC XY: 27AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.502C>T (p.P168S) alteration is located in exon 1 (coding exon 1) of the VEGFB gene. This alteration results from a C to T substitution at nucleotide position 502, causing the proline (P) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at